期刊文献+

DCE-MRI对前列腺平台型强化灶的鉴别诊断价值 被引量:8

DCE-MRI in the Differential Diagnosis of Prostate Lesions with Platform Type of Time-Signal Intensity Curve
原文传递
导出
摘要 目的探讨DCE-MRI定量和半定量参数对时间-信号强度曲线表现为平台型前列腺癌灶和前列腺增生的鉴别诊断价值。方法回顾性分析48例时间-信号强度曲线呈平台型的前列腺疾病患者(前列腺癌26例,前列腺增生22例)DCE-MRI定量和半定量参数,包括容积转移常数(K^(trans))、转移速率常数(K_(ep))、血管外细胞外间隙容积分数(V_e),血容量(BV)、血流量(BF)、达峰时间(TTP)。并运用SPSS进行统计学分析。结果在DCE-MRI时间-信号强度曲线为平台型的前列腺癌灶组和前列腺增生组Ktrans、Kep、BF值分别为(2.33±0.93)min^(-1)和(1.21±0.71)min^(-1)、(3.46±1.41)min^(-1)和(1.81±0.85)min^(-1)、(182.63±74.79)ml·g^(-1)·min^(-1)和(140.88±50.73)ml·g^(-1)·min^(-1),组间差异均有统计学意义(P<0.05)。结论 K^(trans)、K_(ep)、BF值在前列腺癌灶组和前列腺增生组间差异存在统计学意义,DCE-MRI定量和半定量参数对平台型时间-信号强度曲线的前列腺癌灶和前列腺增生间的鉴别具有一定的价值。 Objective To assess the quantitative and semi-quantitative parameters of DCE-MRI for the differentiation of prostate lesions with platform type of time-signal intensity curve. Methods Forty eight patients with platform type of time-signal intensity curve in prostate diseases underwent DCE-MRI at 3. 0 T MRI,which includes 26 patients with prostate cancer and 22 with prostate hyperplasia. Ktrans,Kep,Ve,BV,BF and TTP parameters were compared between prostate cancer and benign nodules. All patients received conventional MRI and DCE-MRI scan. Results The average values of Ktrans,Kep,BF for prostate cancer and begin lesions were( 2. 33 ± 0. 93) min-1vs( 1. 21 ± 0. 71) min-1,( 3. 46 ± 1. 41) min-1vs( 1. 81 ± 0. 85) min-1,( 182. 63 ± 74. 79) ml·g-1·min-1vs( 140. 88 ± 50. 73) ml·g-1·min-1,respectively. There was statistically significant difference in Ktrans,Kep,BF between prostate cancer and begin nodules( P 〈 0. 05). Conclusion Quantitative and semiquantitative assessments of Ktrans,Kepand BF in DCE-MRI is useful in the differentiation of prostate cancer and begin nodules.
出处 《临床放射学杂志》 CSCD 北大核心 2016年第4期589-592,共4页 Journal of Clinical Radiology
关键词 磁共振动态增强扫描 定量评估 半定量评估 前列腺癌 前列腺增生 DCE-MRI Quantitative assessment Semi-quantitative assessment Prostate cancer Prostate hyperplasia
  • 相关文献

参考文献5

二级参考文献83

  • 1倪新初,沈钧康,陆之安,钱农,周丽娟,杨晓春,王灌忠,张彩元,王水珍,项剑波,潘昌杰,荣伟良,陈建国南京医科大学附属常州市第二人民医院泌尿外科,单玉喜,钱铭辉.前列腺癌与良性前列腺增生症的MR动态增强与血管生成的相关性研究[J].中华放射学杂志,2005,39(1):54-59. 被引量:51
  • 2周桥.前列腺癌Gleason分级[J].中华病理学杂志,2005,34(4):240-243. 被引量:44
  • 3Beyersdorff D, Taupitz M, Winkelmann B, et al. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging[J]. Radiology, 2002, 224(3) : 701- 706.
  • 4Lovett K, Rifkin M, McCue P A, et al. MR imaging characteris- tics of noncancerous lesions of the prostate[J]. J Magn Reson Im- aging, 1992, 2(1):35-39.
  • 5Turnbull L W, Buckley D L, Turnbull L S, et al. Differentiation of prostatic carcinoma and benign prostatic hyperplasia: correla- tion between dynamic Gd-DTPA-enhanced MR imaging and histo- pathologyl[J]. J Magn Reson Imaging, 1999, 9(2):311-316.
  • 6Barentsz J O, Engelbrecht M, Jager G J, et al. Fast dynamic gadolinium-enhanced MR imaging of urinary bladder and prostate cancer[J]. J Magn Reson Imaging, 1999, 10(3):295-304.
  • 7Padhani A R, Gapinski C J, Maevicar DA, et ai. Dynamic con- trast enhanced MRI of prostate cancer: correlation with morpho[ ogy and tumor stage, histological grade and PSA[J]. Clin Radiol, 2000, 55(2) :99-109.
  • 8Muramoto S, Uematsu H, Kimura H, et al. Differentiation of prostate cancer from benign prostate hypertrophy using dua[echo dynamic contrast MR imaging[J]. Eur J Radiol, 2002, 44(1) :52 -58.
  • 9Noworolski S M, Henry R G, Vigneron D B, et al. Dynamic con- trast enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI[J]. Magn Reson Med, 2005, 53(2):249-255.
  • 10Gibbs P, Liney G P, Lowry M, et al. Differentiation of benign and malignant sub-1 cm breast lesions using dynamic contrast en- hanced MRI[J]. Breast, 2004, 13(2):115-121.

共引文献112

同被引文献71

引证文献8

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部